Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Rang in Aktien
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Aktienkurs
$8.03
Marktkapitalisierung
$6.31B
Veränderung (1 Tag)
1.07%
Veränderung (1 Jahr)
-8.04%
Land
CN
Handel Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Kategorie
Healthcare
Dividendenrendite-Verlauf für Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Dividendenrendite (TTM) von Shenzhen New Industries Biomedical Engineering Co., Ltd. (Aktienkürzel: 300832) zum 2024-12-31: 1.41%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 1.40%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 1.40%
Dividendenrendite-Verlauf für Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832) von 2012 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
| Jahr | Dividendenrendite | ändert |
|---|---|---|
| 2026 (TTM) | 2.24% | -3.03% |
| 2025 | 2.31% | 63.83% |
| 2024 | 1.41% | 56.67% |
| 2023 | 0.90% | -25.00% |
| 2022 | 1.20% | 0.84% |
| 2021 | 1.19% | 4.39% |
| 2020 | 1.14% | 0.00% |
| 2019 | 0.00% | -100.00% |
| 2018 | 0.60% | -45.95% |
| 2017 | 1.11% | 236.36% |
| 2016 | 0.33% | 26.92% |
| 2015 | 0.26% | 85.71% |
| 2014 | 0.14% | 100.00% |
| 2013 | 0.07% | 16.67% |
| 2012 | 0.06% | 0.00% |
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | Dividendenrendite | Land |
|---|---|---|
| 2.51% |
US
|
|
| 3.02% |
IE
|
|
| 1.14% |
US
|
|
| 0.00% |
US
|
|
| 2.39% |
DE
|
